FDA approves first targeted therapy to treat a rare mutation in patients with gastrointestinal… EP News Bureau Jan 10, 2020 Ayvakit is a kinase inhibitor, meaning it blocks a type of enzyme called a kinase and helps keep the cancer cells from growing
FDA approves first targeted therapy to treat patients with painful complication of sickle cell… EP News Bureau Nov 19, 2019 Sickle cell disease is an inherited blood disorder in which the red blood cells are abnormally shaped which restricts the flow in…
